Pharvaris (PHVS) Receivables (2019 - 2026)
Pharvaris (PHVS) recorded Receivables of $1.24 trillion in Q2 2026, compared with $2.94 million a year earlier and up 9.6% from the prior quarter.
Powered by 
Analysis
Pharvaris (PHVS) Receivables (2019 - 2026) Analysis & Trends
At the end of FY2025, Pharvaris reported Receivables of $629.01 billion, up 26.9% from FY2024.
- Annual Receivables has increased for three straight years, though with a five-year compound annual growth rate of -0.7% (FY2020 to FY2025).
- Across earlier years, Receivables came in at $495.53 billion in FY2024 (+8.2%), $458.09 billion in FY2023 (+13.6%), $403.1 billion in FY2022 (-51.3%) and $828.47 billion in FY2021 (+27.4%).
- The Q2 2026 figure is the highest quarterly Receivables in data going back to Q4 2019.
- On a year-over-year basis, Receivables rose in two of the last five quarters, with an average decline of 36.4%.
- Peak year-over-year performance for Receivables in the last five years was growth of 110.8% in Q3 2024, against a decline of 100.0% in Q1 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,128.06 Bn | 1,096.64 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 615.47 Bn | 534.00 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 504.80 Bn | 477.91 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 368.45 Bn | 322.83 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.44 Bn | 262.43 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.92 Bn | 235.60 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 236.10 Bn | 191.50 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 190.71 Bn | 164.91 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.16 Bn | 116.81 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Pharvaris | 1.83 Bn | 457.84 Mn | - | 6.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.02 Mn |
| Mar 31, 2026 | 1.11 Mn |
| Dec 31, 2025 | 12.82 Mn |
| Jun 30, 2025 | 3.05 Mn |
| Mar 31, 2025 | 631,166.37 |
| Dec 31, 2024 | 3.06 Mn |
| Sep 30, 2024 | 720,890.93 |
| Jun 30, 2024 | 1.73 Mn |
| Mar 31, 2024 | 391,916.00 |
| Dec 31, 2023 | 1.15 Mn |
| Sep 30, 2023 | 326,216.01 |
| Jun 30, 2023 | 363,317.14 |
| Mar 31, 2023 | 429,732.61 |
| Dec 31, 2022 | 407,739.70 |
| Sep 30, 2022 | 397,266.41 |
| Jun 30, 2022 | 346,751.62 |
| Mar 31, 2022 | 746,742.40 |
| Dec 31, 2021 | 792,841.42 |
| Sep 30, 2021 | 733,647.02 |
| Jun 30, 2021 | 848,327.78 |
API Access
Pharvaris Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=PHVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "PHVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=PHVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();